Skip to main content

Table 1 Polycomb genes expression in normal brain and specific tumor histologies.

From: Clinical significance of Polycomb gene expression in brain tumors

PRC

GENE

Category 1

(up-regulated)

Category 2

(down- regulated)

P value

1

BMI1

Normal Brain

Glioblastoma

5.85 E-27

 

CBX2

Neural Stem Cell

Glioblastoma

4.4 E-13

 

CBX7

Normal Brain

Glioblastoma

2.2 E-27

  

Ganglioneur-oma/-oblastoma

Neuroblastoma

2.4 E-7

 

PCGF1

Glioblastoma

Astrocytoma

1.2 E-6

 

PCGF6

Astrocytoma/Oligodendroglioma

Glioblastoma

4.0 E-6

 

PHC2

Astrocytoma/Glioblastoma

Oligodendroglioma

1.4 E-7

 

YY1

Anaplastic Oligoastrocytoma

Normal Brain

1.23 E-5

  

Medulloblastoma with Advanced Neural Differentiation

Other hystologies

8.86 E-27

  

Oligodendroglioma

Mixed Glioma

3.83 E-6

2, 3, 4

EZH2

Anaplastic Oligodendroglioma

Normal Brain

1,12E-12

  

Anaplastic Astrocytoma

Normal Brain

3,50E-13

  

Glioblastoma

Normal Brain

2,56E-23

  

Neuroblastoma

Ganglioneur-oma/-oblastoma

4,94E-08

  

Glioblastoma

Astrocytoma/Ogligodendroglioma

1.64 E-5

 

RBBP7

Anaplastic Astrocytoma

Normal Brain

6,0E-06

  

Anaplastic Oligodenroglioma

Normal Brain

5,60E-08

 

SUZ 12

Anaplastic Oligodendroglioma

Normal Brain

1.19 E-7

  

Atypical Theratoid/Rhabdoid Tumor

Medulloblastoma

5.50 E-8

4

SIRT1

Neural Stem Cell

Glioblastoma

9.4 E-13

  

Oligodendroglioma

Glioblastoma Astrocytoma

1.9 E-11

  1. Data derived from Oncomine database. Grading analyses were performed on 35 adult and 19 pediatric brain tumors. Survival analysis was performed on a total of 97 glioblastoma patients.